Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006272
Filing Date
2022-04-28
Accepted
2022-04-28 16:06:20
Documents
4
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220615xdef14a.htm DEF 14A 645957
2 GRAPHIC tmb-20220615xdef14a001.jpg GRAPHIC 10189
3 GRAPHIC tmb-20220615xdef14a013.jpg GRAPHIC 197978
4 GRAPHIC tmb-20220615xdef14a012.jpg GRAPHIC 250277
  Complete submission text file 0001558370-22-006272.txt   1278786
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37719 | Film No.: 22866493
SIC: 2834 Pharmaceutical Preparations